AskVantage

Chintu Patel

Chintu Patel is number 191 in the 311 Private Wealth Index, with disclosed holdings in listed companies worth about $653m, mainly in Amneal Pharmaceuticals, Inc. That is about 3,391 times the wealth of a typical US household. Chintu Patel is a director and co-chief executive officer of Amneal Pharmaceuticals, Inc.

Part of the 311 Private Wealth Index (311institute.com). Last updated .

#191Rank
$653mDisclosed holdings
3,391×Times a typical US household
Amneal Pharmaceuticals, Inc.Main source
Co-chief executive officerRole
Book a Briefing

Disclosed holdings

CompanyValueLatest filingShares
Amneal Pharmaceuticals, Inc.$653m12 August 202633,941,011 at $19.25 (closing price, 15 October 2026)

How this figure is calculated

Shares reported in SEC insider filings (Forms 3, 4 and 5), at the latest holding each filing reports, valued at the latest price disclosed in those filings, or at the latest closing price where no recent trade price was filed. Holdings that the filings say belong to investment funds managed by the person are left out, and shares reported jointly by several family members are counted once. Private companies, cash, property and holdings listed outside the United States are not included, so this is a minimum, not total wealth. The household comparison uses $192,700, the median US household wealth in the Federal Reserve Survey of Consumer Finances (2022, the latest published).

Related

Others in the index with Amneal Pharmaceuticals, Inc. as their main holding

Questions and answers

What is Chintu Patel's net worth?

Chintu Patel has disclosed holdings in listed companies worth about $653m, according to the 311 Private Wealth Index. This is a minimum: private companies, cash and property are not included.

How much are Chintu Patel's disclosed holdings worth?

About $653m in listed companies, ranking Chintu Patel number 191 in the 311 Private Wealth Index.

Where does Chintu Patel's wealth come from?

Mainly from holdings in Amneal Pharmaceuticals, Inc. Chintu Patel is a director and co-chief executive officer of Amneal Pharmaceuticals, Inc.

Source: SEC insider filings.

© 311 Institute 2026. Facts from official filings and the sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.